First report on the synthesis and structural studies of trans-Phakellistatin 18: a rotamer of marine natural product phakellistatin 18

References

• Ali H, Jabeen A, Maharjan R, Nadeem-Ul-Haque M, Aamra H, Nazir S, Khan S, Olleik H, Maresca M, Shaheen F. 2020. Furan-conjugated tripeptides as potent antitumor drugs. Biomolecules. 10(12):1684.
   PubMed Web of Science ®Google Scholar
• Bajaj K. 2019. Natural bioactive cyclic peptides and peptidomimetics. Studies in natural products chemistry. Elsevier (Amsterdam); 62:343–376.
   Google Scholar
• Chiangjong W, Chutipongtanate S, Hongeng S. 2020. Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review). Int J Oncol. 57(3):678–696.
   PubMed Web of Science ®Google Scholar
• Dahiya R, Dahiya S. 2021. Natural bioeffective cyclooligopeptides from plant seeds of Annona genus. Eur J Med Chem. 214:113221.
   PubMed Web of Science ®Google Scholar
• Daly NL, Wilson DT. 2021. Plant derived cyclic peptides. Biochem Soc Trans, 49(3):1279–1285.
   Google Scholar
• Duan M, Mahal A, Mohammed B, Zhu Y, Tao H, Mai S, Al-Haideri M, Zhu Q. 2021. Synthesis and antitumor activity of new tetrahydrocurcumin derivatives via click reaction. Nat Prod Res. 1–9. doi:10.1080/14786419.2021.1931181.
   Google Scholar
• Fang W-Y, Dahiya R, Qin H-L, Mourya R, Maharaj S. 2016. Natural proline-rich cyclopolypeptides from marine organisms: Chemistry, synthetic methodologies and biological status. Mar Drugs. 14(11):194.
   PubMed Web of Science ®Google Scholar
• Fisher MF, Payne CD, Chetty T, Crayn D, Berkowitz O, Whelan J, Rosengren KJ, Mylne JS. 2020. The genetic origin of evolidine, the first cyclopeptide discovered in plants, and related orbitides. J Biol Chem. 295(42):14510–14521.
   PubMed Web of Science ®Google Scholar
• Fu D, Rao X, Xu J, Tanabe G, Muraoka O, Wu X, Xie W. 2018. First total synthesis of cyclic pentadepsipeptides Hikiamides A–C. Tetrahedron Lett. 59(30):2876–2879.
   Web of Science ®Google Scholar
• Fung S, Hruby VJ. 2005. Design of cyclic and other templates for potent and selective peptide alpha-MSH analogues. Curr Opin Chem Biol. 9(4):352–358.
   PubMed Web of Science ®Google Scholar
• Gogineni V, Hamann MT. 2018. Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology. Biochim Biophys Acta Gen Subj BBA-GEN Subjects. 1862(1):81–196.
   PubMed Web of Science ®Google Scholar
• Jing X, Jin K. 2020. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies. Med Res Rev. 40(2):753–810.
   PubMed Web of Science ®Google Scholar
• Joo SH. 2012. Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther (Seoul)). 20(1):19–26.
   PubMed Web of Science ®Google Scholar
• Kwon O-S, Kim C-K, Byun WS, Oh J, Lee Y-J, Lee H-S, Sim CJ, Oh D-C, Lee SK, Oh K-B, et al. 2018. Cyclopeptides from the Sponge Stylissa flabelliformis. J Nat Prod. 81(6):1426–1434.
   PubMed Web of Science ®Google Scholar
• Liu W, de Veer SJ, Huang Y-H, Sengoku T, Okada C, Ogata K, Zdenek CN, Fry BG, Swedberg JE, Passioura T. 2021. An ultrapotent and selective cyclic peptide inhibitor of human β-factor XIIa in a cyclotide scaffold. J Amer Chem Soc.143(44):18481–18489.
   PubMed Web of Science ®Google Scholar
• Macedo MWFS, Cunha NBD, Carneiro JA, Costa RAD, Alencar S, Cardoso MH, Franco OL, Dias SC. 2021. Marine organisms as a rich source of biologically active peptides. Front Mar Sci. 8:889.
   Web of Science ®Google Scholar
• Mahal A, Wu P, Jiang Z-H, Wei X. 2017. Synthesis and cytotoxic activity of novel tetrahydrocurcumin derivatives bearing pyrazole moiety. Nat Prod Bioprospect. 7(6):461–469.
   PubMed Web of Science ®Google Scholar
• Mahal A, Wu P, Jiang ZH, Wei X. 2019. Schiff bases of tetrahydrocurcumin as potential anticancer agents. ChemistrySelect. 4(1):366–369.
   Web of Science ®Google Scholar
• Malesevic M, Strijowski U, Bächle D, Sewald N. 2004. An improved method for the solution cyclization of peptides under pseudo-high dilution conditions. J Biotechnol. 112(1/2):73–77.
   PubMed Web of Science ®Google Scholar
• Meli A, Tedesco C, Della Sala G, Schettini R, Albericio F, De Riccardis F, Izzo I. 2017. Phakellistatins: an underwater unsolved puzzle. Mar Drugs. 15(3):78.
   PubMed Web of Science ®Google Scholar
• Morita H, Gonda A, Takeya K, Itokawa H, Shirota O. 1997. Cyclic peptides from higher plants. Part 32. Conformational preference of cycloleonuripeptides A, B, and C, three proline-rich cyclic nonapeptides from Leonurus heterophyllus. Chem Pharm Bull. 45(1):161–164.
   Web of Science ®Google Scholar
• Napolitano A, Bruno I, Riccio R, Gomez-Paloma L. 2005. Synthesis, structure, and biological aspects of cyclopeptides related to marine phakellistatins 7–9. Tetrahedron. 61(28):6808–6815.
   Web of Science ®Google Scholar
• Napolitano A, Rodriquez M, Bruno I, Marzocco S, Autore G, Riccio R, Gomez-Paloma L. 2003. Synthesis, structural aspects and cytotoxicity of the natural cyclopeptides yunnanins A, C and phakellistatins 1, 10. Tetrahedron. 59(51):10203–10211.
   Web of Science ®Google Scholar
• Ngenge TA, Jabeen A, Maurice TF, Baig TA, Shaheen F. 2019. Organic and mineral composition of seeds of Afrostyrax lepidophyllus Mildbr. and evaluation of ROS inhibition and cytotoxicity of isolated compounds. Chemistry Africa. 2(4):615–624.
   Google Scholar
• Ogunlakin AD, Sonibare MA, Jabeen A, Shaheen F, Shah SF. 2021. Antiproliferative and ameliorative effects of Tetracera potatoria and its constituent. Adv Tradit Med (Adtm)). 21(4):815–810.
   Google Scholar
• Prior AM, Hori T, Fishman A, Sun D. 2018. Recent reports of solid-phase cyclohexapeptide synthesis and applications. Molecules. 23(6):1475.
   PubMed Web of Science ®Google Scholar
• Pujals S, Giralt E. 2008. Proline-rich, amphipathic cell-penetrating peptides. Adv Drug Deliv Rev. 60(4/5):473–484.
   PubMed Web of Science ®Google Scholar
• Roxin Á, Zheng G. 2012. Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides. Future Med Chem. 4(12):1601–1618.
   PubMed Web of Science ®Google Scholar
• Shah ZA, Hameed A, Ahmed A, Simjee SU, Jabeen A, Ullah A, Shaheen F. 2016. Cytotoxic and anti-inflammatory salicin glycosides from leaves of Salix acmophylla. Phytochem Lett. 17:107–113.
   Web of Science ®Google Scholar
• Shaheen F, Jabeen A, Ashraf S, Nadeem‐Ul‐Haque M, Shah ZA, Ziaee MA, Dastagir N, Ganesan A. 2016. Total synthesis, structural, and biological evaluation of stylissatin A and related analogs. J Pept Sci. 22(9):607–617.
   PubMed Web of Science ®Google Scholar
• Shaheen F, Rizvi TS, Musharraf SG, Ganesan A, Xiao K, Townsend JB, Lam KS, Choudhary MI. 2012. Solid-phase total synthesis of cherimolacyclopeptide E and discovery of more potent analogues by alanine screening. J Nat Prod. 75(11):1882–1887.
   PubMed Web of Science ®Google Scholar
• Tan G, Gyllenhaal C, Soejarto D. 2006. Biodiversity as a source of anticancer drugs. Curr Drug Targets. 7(3):265–277.
   PubMed Web of Science ®Google Scholar
• Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, et al. 2012. Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides. J Biol Chem. 287(41):34120–34133.
   PubMed Web of Science ®Google Scholar
• Wu M-h, Li Y-l, Chang Q, Zhao X, Chen Q. 2018. Total synthesis and modification of proline-rich cyclopeptides Phakellistatins 17 and 18 isolated from marine sponge. Tetrahedron Lett. 59(45):4011–4014.
   Web of Science ®Google Scholar
• Yang L, Li H, Wu P, Mahal A, Xue J, Xu L, Wei X. 2018. Dinghupeptins A–D, chymotrypsin inhibitory cyclodepsipeptides produced by a soil-derived streptomyces. J Nat Prod. 81(9):1928–1936.
   PubMed Web of Science ®Google Scholar
• Zhang H-J, Yi Y-H, Yang G-J, Hu M-Y, Cao G-D, Yang F, Lin H-W. 2010. Proline-containing cyclopeptides from the marine sponge Phakellia fusca. J Nat Prod. 73(4):650–655.
   PubMed Web of Science ®Google Scholar
• Zhang J-N, Xia Y-X, Zhang H-J. 2021. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years. IJMS. 22(8):3973.
   Google Scholar
• Zheng L, Xu Y, Lin X, Yuan Z, Liu M, Cao S, Zhang F, Linhardt RJ. 2018. Recent progress of marine polypeptides as anticancer agents. Recent Pat Anticancer Drug Discov. 13(4):445–454.
   PubMed Web of Science ®Google Scholar
• Zheng L-H, Wang Y-J, Sheng J, Wang F, Zheng Y, Lin X-K, Sun M. 2011. Antitumor peptides from marine organisms. Mar Drugs. 9(10):1840–1859.
   PubMed Web of Science ®Google Scholar